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Abstract
Background: Grading of dysplasia, including head and neck lesions, continues to be a hotly
debated subject. It is subjective and lacks intra- and inter-observer reproducibility due to the
insufficiency of validated morphological criteria and the biological nature of dysplasia. Moreover,
due to the absence of a consensus, several systems are currently employed.
Objectives: The aims of this review are to:
1) Highlight the significance of dysplasia and the importance of a valid method for assessing
precursor lesions of the head and neck.
2) Review the different histopathological classification systems for grading intraepithelial lesions of
the head and neck.
3) Discuss and review quality requirements for these grading systems.
Conclusion:  Regarding the different classification systems, data concerning the WHO
classification system are the most available in current literature. There is no simple relationship or
overlapping between the classification systems. Further studies should be done to see whether
other systems have advantages above the current WHO system and to discover indications that
could lead to an universal classification system for intraepithelial lesions of the head and neck.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is one
of the most often encountered malignancies; it carries a
bad prognosis.[1,2] To improve survival, adequate diag-
nosis and treatment of precursor lesions is urgently
needed. These precursor lesions are defined as an altered
epithelium with an increased likelihood for progression
to squamous cell carcinoma (SCC). The altered epithe-
lium shows a variety of cytological and architectural
changes that have traditionally brought under the com-
mon denominator dysplasia.[3]
The presence of dysplastic areas in the epithelium of the
upper aerodigestive tract (UADT) is believed to be associ-
ated with a likely progression to cancer. There is evidence
that in an individual lesion, the more severe the dysplasia
the greater the likelihood is of progression to malignancy.
Rarely however, non-dysplastic lesions may also show
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malignant development .[3-8] Therefore, presence and
severity of dysplasia cannot be used as a reliable guide for
the treatment of individual cases. Nevertheless, the crude
relationship between grading dysplasia and risk of pro-
gression to malignancy makes dysplasia grading neces-
sary.
Grading of dysplasia, including head and neck lesions,
continues to be a hotly debated subject. It is subjective
and lacks intra- and inter-observer reproducibility due to
the insufficiency of validated morphological criteria and
the biological nature of dysplasia .[8-10] Moreover, due to
the absence of a consensus, several systems are currently
employed.[11]
Nevertheless conventional histopathological evaluation
based on light microscopic examination of hematoxylin &
eosin-stained slides is, in spite of the above mentioned
shortcomings, still the most valid method for assessing
the malignant potential of preneoplastic head and neck
lesions.[4] Moreover, it is important to notice that making
a diagnosis is a prerequisite for selecting the treatment
which ensures the best prognosis, making the disease clas-
sification system a predictive system.[8,12] The aim
should be to tailor forms of therapy to the likelihood of
disease progression thus reducing the incidence of inva-
sive disease, limiting the need for radical surgery and
improving survival while avoiding unnecessary follow-up
in cases which lack significant premalignant poten-
tial.[10]
Grading systems: overview
During the last decades many classifications of intraepi-
thelial head and neck lesions have been proposed as illus-
trated by the fact that for intraepithelial laryngeal lesions,
more than 20 classification systems have been described
.[13-18] This seriously hampers the assessment of the
long-term risk of subsequent malignancy, because differ-
ent histopathological classifications and initial interven-
tions make comparison of reported data difficult or even
impossible because of inconsistencies in the criteria used
for evaluation of the histological features.[8,19,20] The
need for uniformity in reporting these lesions is obvious.
The majority of the classifications in the current literature
have followed criteria similar to those in common use for
the grading of epithelial lesions of the uterine cer-
vix.[21,22] Whether this is justified, is debatable. In cervi-
cal epithelium, there is clear distinction between normal
and abnormal layers of the epithelium and consequently
the degree of dysplasia can be assessed by determining the
horizontal level of this border in the epithelium, resulting
in substantial intra- and inter-observer consistency. Such
a sharp distinction between normal and abnormal layers
in the epithelium of the UADT is less obvious and conse-
quently the definition of the degree of dysplasia is much
more susceptible for discussion, this resulting in substan-
tial intra- and inter-observer variability.[8,10,23]
When looking at the current classification systems as men-
tioned in the WHO-IARC blue book series the following
ones are proposed. The WHO classification is similar to
the classification for the uterine cervix, and is widely used
in spite of the shortcomings as mentioned. It recognizes
low, moderate and severe dysplasia and carcinoma in situ
(CIS), defined in the same way as for cervical lesions. The
SIN classification (squamous intraepithelial neoplasia)
can be considered synonymously, excepted that severe
dysplasia and CIS are combined as SIN 3 (Table 1).
Besides the WHO and SIN classification system, the
Ljubljana classification is mentioned (Table 1).[3,11]
The Ljubljana classification, developed by laryngeal
pathologists and used since 1971, focuses on the clinical
Table 1: Classification systems that categorize intraepithelial head and neck lesions.[3,11]
2005 WHO Classification Squamous Intraepithelial Neoplasia (SIN) Ljubljana Classification Squamous Intraepithelial Lesions 
(SIL)
squamous cell hyperplasia squamous cell (simple) hyperplasia
mild dysplasia SIN 1 basal/parabasal cell hyperplasia*
moderate dysplasia SIN 2 atypical hyperplasia**
severe dysplasia SIN 3*** atypical hyperplasia**
carcinoma in-situ SIN 3*** carcinoma in-situ
* basal/parabasal cell hyperplasia may histologically resemble mild dyplasia, but the former is conceptually benign lesion and the latter the lower 
grade of precursor lesions.
** 'risky epithelium'. The analogy to moderate and severe dysplasia is approximate.
*** the advocates of SIN combine severe dysplasia and carcinoma in-situ.Head & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/11
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decision points which involve the identification of: 1)
purely hyperplastic lesions that do not require close fol-
low-up (simple or abnormal hyperplasia), 2) mild
degrees of atypia who require close follow-up to recognize
any progression to severe atypia (atypical or 'risky' hyper-
plasia), 3) severe atypia (carcinoma in situ) who require
treatment (surgery or radiotherapy).[4,16,19,24,25]
Apart from these taxonomic problems, the need to differ-
entiate between severe dysplasia and carcinoma in situ is
debatable. Several authors have commented on the diffi-
culty in separating these categories in conventional classi-
fication systems.[4,5,13] To reduce categories still further,
occasionally a binary classifying system has been pro-
posed.[10,26]
Quality requirements for grading systems
A grading system can be devised in two ways: an arbitrary
system can be composed with no detailed knowledge of
the domain, or data about the domain can be used in sta-
tistical methods of analysis. Since most grading and scor-
ing systems in histopathology are imposed on domains
without prior data analysis, the psychological factors that
affect the creation of these systems becomes important.
There is often an interaction between histopathological
grading systems and clinical therapies especially if trials of
treatment for a particular condition are widespread. Some
authors suggest that the pathologist is required only to
divide cases into the number of different treatment
options available. Others, including Morris, argue that the
pathologist should transmit the maximum amount of
information possible from their interpretations without
the addition of extraneous 'noise'.[27,28] Furthermore,
reproducibility and prognostic value (use of results) are
important conditions.
Reproducibility
Reproducibility refers to the degree to which observer
measurement or diagnosis remains the same on repeated
independent observations of an unchanged characteris-
tic.[29] This consistency can be assessed between different
observers (interobserver) or within a single observer
(intraobserver). When studying the accuracy in grading
dysplasia of the UADT there is no test available, which is
thought to be better than the pathologist's observation; an
accepted gold standard is not available for assessing the
validity obtained when grading these lesions. Therefore,
reproducibility, normally used to assess precision, is used
to provide an indication of validity. When combined for
this goal, inter- and intraobserver agreement levels give an
estimate of the degree of bias and validity in situations
(like grading dysplasia of the UADT), where an appropri-
ate gold standard is not available.[30]
If a scoring system is to be clinically useful then it should
be reproducible both between pathologists and for the
same pathologist at different times: inter- and intra-
observer reproducibility.[27] In histopathology, results of
the diagnostic evaluation are discrete diagnostic catego-
ries (for example, moderate dysplasia in a laryngeal
lesion) rather than variable parameters and for this reason
kappa statistics are often used as indicators of perform-
ance .[31-33] Kappa statistics measure levels of agreement
between observers and make allowance for the degree of
agreement that would occur by chance alone.[34] Since
most grading systems in squamous lesions produce an
ordinal categorical result then kappa statistics are a rele-
vant means of assessing reproducibility.[8,27,32,34,35] A
kappa statistic of 1 represents perfect agreement and 0 rep-
resents the level of agreement expected by chance
alone.[27] Landis et al. described guidelines to interpret
the quantitative significance of kappa.[31]
Concerning the head and neck region, data of oral lesions
outnumber laryngeal lesions. Pindborg et al. for the first
time indicated the need for an internationally accepted set
of criteria for oral epithelial dysplasia in 1975.[36] Since
then, several studies have shown large intra- and interob-
server variability in the assessment of intraepithelial head
and neck lesions (Table 2).[10,26,30,36-41]
There are also additional features that negatively influence
reproducibility. Fischer et al. suggested that inflamma-
tion, lesion site, and biopsy technique (punch and wedge)
modifies the reliability of oral histological lesions.[38]
Clinical information submitted with biopsy specimens
did not increase accuracy and consistency.[41]
With these considerations in mind, reproducibility for the
larynx gave an overall kappa value of 0.32 for the WHO
classification, whereas the use of a two grade system (low
and high grade) gave a kappa figure of 0.52.[10] Data con-
cerning the SIN classification and Ljubljana classification
in relation to reproducibility of laryngeal lesions are not
available in current literature. Agreement for lesions of the
oral cavity and oropharynx varies from 35.8 to 92.8% for
the WHO classification, kappa values varying from 0.15 to
0.59.[26,30,37-41] A binary system (high/low risk), eval-
uated by Kujan et al., resulted in 74.3% agreement and a
kappa value of 0.50. Particularly for the cases of moderate
dysplasia the binary grading system may have merit in
helping clinicians to make critical decisions.[26] Fischer et
al. also reduced the number of pathologic diagnoses to
three categories ('no abnormality/hyperkeratosis', 'mild,
moderate, or severe dysplasia', 'carcinoma in situ/carci-
noma') which resulted in a kappa value of 0.70 (com-
pared with 0.59 using the various pathologic diagnoses
separately).[38] Data concerning the SIN classification
and Ljubljana classification in relation to reproducibilityHead & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/11
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of oropharyngeal lesions and lesions of the oral cavity are
not available in current literature. Table 2 shows an over-
view of observer variability in head and neck lesions.
Prognostic and predictive value
Altmann et al. and Putney et al. reported the first follow-
up studies of precancerous conditions of the larynx; carci-
noma in situ and keratosis, respectively.[42,43] Since then
several follow-up studies concerning the natural evolu-
tion and long-term risk of malignant progression in
intraepithelial lesions have been reported. In these stud-
ies, usually no distinction between natural evolution
without treatment (prognostic value) and predictive value
(response to treatment) is made. Therefore, data on malig-
nant progression as summarized below concern both
treated and untreated cases.
Malignant progression of intraepithelial laryngeal lesions
diagnosed with the WHO classification is, according to
current literature, as follows: hyperplasia 0–
3%.[13,44,45], mild dysplasia 0–30% [13,45-47], moder-
ate dysplasia 0–44% [5,13,45-49], severe dysplasia 20–
57% [13,45,47,49,50], CIS 0–80% [13,44,45,48-52].
Regarding the SIN classification, relevant figures are as fol-
lows: SIN I 5%, SIN II 25%, and SIN III 11–25%.[5,53]
Table 2: Observer variability in head and neck lesions.
Studies/
References
Localisation Number of 
slides
Histopathologic
al classification
Number of 
examinators
Agreement Kappa value
Abbey et al. 1995 oral cavity/
oropharynx
120 WHO° 6 35.8–57.5% 0.15–0.41
Fischer et al. 20041 oral cavity/
oropharynx
87 WHO° 24 0.59 
(95% CI: 0.45–
0.72)
0.70 (95% CI: 
0.56–0.84)2
Karabulut et al. 
1995
oral cavity/
oropharynx
100 WHO° 4 49–69% 27–45%3
Tabor et al. 2003 oral cavity/
oropharynx
43 WHO 3 53% 0.58
Abbey et al. 1998 oral cavity/
oropharynx
120 WHO° 6 38.5% 0.174
Brothwell et al. 
2003
oral cavity/
oropharynx
64 WHO° 3 51% 0.37
Kujan et al. 20061 oral cavity/
oropharynx
68 WHO and binary 
system 
("low-risk" or 
"high-risk")
4W H O :
37.7% 
(unweighted)
92.8% (weighted)
Binary system:
74.3%
WHO:
0.22 (95% CI: 
0.11–0.35 
unweighted)
0.63 (95% CI: 
0.42–0.78 
weighted)
Binary system:
0.50
Mclaren et al. 2000 larynx 100 WHO and two-
grade 
(low and high 
grade)
13 WHO: 0.32
Two-grade: 0.52
° = WHO is not explicitely stated, but terms are in agreement with this system.
1 = The unweighted kappa considers all disagreements to be equally important, while the weighted kappa (Kw) yields a higher reliability when 
disagreements between raters are small compared with when they are large.
2 = the pathologic diagnoses are restricted to three categories ('no abnormality/hyperkeratosis', 'mild, moderate, or severe dysplasia', 'carcinoma in 
situ/carcinoma').
3 = when comparing the kappa values between the two pairs of pathologists with the same education, these values did not diverge from the general 
level of kappa values, indicating that the interobserver variability was due to individual differences rather than to educational background.
4 = Clinical information submitted with biopsy. Same population as [37].Head & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/11
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Photomicrograph showing area of increased epithelial thick- ness together with hyperkeratosis: mild dysplasia (WHO) or  parabasal hyperplasia (Ljubljana) Figure 1
Photomicrograph showing area of increased epithe-
lial thickness together with hyperkeratosis: mild dys-
plasia (WHO) or parabasal hyperplasia (Ljubljana).
Photomicrograph showing blunt and elongated epithelial  ridges and cytonuclear atypia confined to the lower epithelial  half: moderate dysplasia (WHO) or atypical hyperplasia  (Ljubljana) Figure 2
Photomicrograph showing blunt and elongated epi-
thelial ridges and cytonuclear atypia confined to the 
lower epithelial half: moderate dysplasia (WHO) or 
atypical hyperplasia (Ljubljana).
Clinical data concerning follow-up on laryngeal lesions
graded with the Ljubljana classification showed a marked
increase in the incidence of malignant progression from
simple, abnormal, and atypical hyperplasia (resp. 0.7%,
1.0%, and 9.5%).[25] Recently, a study by Gale et al.
showed 1.1% (12/1089) progression to carcinoma of
squamous hyperplasia/basal-parabasal hyperplasia and
9.5% (17/179) of atypical hyperplasia (CIS is not
included).[20]
Few studies have examined the cancer risk related to dif-
ferent grades of oral dysplasias .[54-57] Silverman et al.
reported malignant transformation in 36% of cases with
oral dysplasia. The degree of dysplasia is not speci-
fied.[56] Schepman et al. reported 12% malignant trans-
formation in oral lesions histopathological classified with
the WHO classification. Leukoplakias consisting of mod-
erate or severe epithelial dysplasia, had a significantly
higher risk of developing a carcinoma than leukoplakias
of a lower stage (p < 0.01).[55] In another study 26% of
cases with hyperplasia/mild dysplasia and 67% of cases
with moderate/severe dysplasia developed into carci-
noma.[54] Lumerman et al. studied malignant transfor-
mation in hyperplasia with dysplasia, mild dysplasia,
moderate dysplasia, severe dysplasia, and CIS; respec-
tively 29%, 8%, 17%, 17%, 0%.[57] Data concerning the
SIN classification in relation to predictive value of oral
lesions are not available in current literature. The only
study in current literature which studied the application
of the Ljubljana classification to grading oral intraepithe-
lial lesions has been published by Zerdoner et al. No cases
of simple (0/79) or abnormal (0/42) hyperplasia showed
progression to carcinoma, 18.2% (2/11) of atypical hyper-
plasia progressed to invasive cancer.[58]
Interpretation of these reported data of oral intraepithelial
lesions are hampered by small sample sizes, surgical inter-
vention carried out for high-risk dysplasias and variability
in reporting dysplasia grades. The greater part of pub-
lished data only considered macroscopical features (i.e.
leukoplakia) and no histology.[59,60] It should also be
noted that the predictive value of dysplasia is dependent
on the prevalence of leukoplakia in a given population.[8]
Size, and not histology seems to be the most important in
predicting malignant transformation.[61]
So, it appears that regarding reproducibility as well as in
terms of prognosis, still a lot of progress has to be made.
Molecular markers are subject of investigation: in spite of
many studies, the molecular events that induce the devel-
opment of premalignancies to carcinoma are still
unknown, and we are still forced to conclude that over (orHead & Neck Oncology 2009, 1:11 http://www.headandneckoncology.org/content/1/1/11
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under)-expression of biomarkers itself adds little predic-
tive value over standard histology .[62-66] Therefore,
until now they are not applicable in clinical practice.[67]
Finally, some remarks have to be made on the relation-
ship between clinical aspects and risk of malignant pro-
gression. In general, homogeneous leukoplakic lesions
are thought to have a low risk of malignant transforma-
tion, mixed white and red lesions (or speckled leukopla-
kia) an intermediate risk, and pure erythroplakia (red
lesions) the highest risk of cancer development. However,
none of these macroscopic features is reliably diagnostic
of any histological grade of precursor lesion, and histolog-
ical analysis of these lesions is mandatory to determine
their biological potential. Occasionally precursor lesions
may appear clinically normal.[3,11,20,68] Furthermore,
nomenclature or terminology concerning the macro-
scopic features is still a subject of discussion.[69]
Evaluation
As outlined before, a histological dysplasia system ideally
should meet two basic requirements. At first, it should be
easily applicable in daily routine practice with low inter-
and intra-observer variability. Secondly, it should allow a
clear separation between patients who need treatment to
prevent progression towards malignancy and those for
whom no treatment is needed.
Regarding inter- and intraobserver variability, evaluation
of the WHO classification shows for laryngeal lesions an
overall kappa value of 0.32, whereas the use of a two grade
system (low and high grade) gave a kappa figure of
0.52.[10] Its prognostic significance is as follows: hyper-
plasia 0–3%.[13,44,45], mild dysplasia 0–30% [13,45-
47], moderate dysplasia 0–44% [5,13,45-49], severe dys-
plasia 20–57% [13,45,47,49,50], CIS 0–80%
[13,44,45,48-52]. For oral lesions, inter- and intraob-
server figures of the WHO classification vary between
kappa scores of 0.15 and 0.59.[26,30,37-41] Its prognos-
tic significance is 12–67%, as can be inferred from the
data mentioned before.
When looking at the SIN classification it has to be noted,
that with respect to reproducibility, no data of head and
neck lesions are available in current literature. Concerning
prognostic significance of laryngeal lesions the following
data are available: SIN I 5%, SIN II 25%, SIN III 11–
25%.[5,53] Data concerning the SIN classification in rela-
tion to predictive value of oral lesions are not available in
current literature.
Regarding the Ljubljana classification, its use for the lar-
ynx has been documented extensively. Its relevance for
prognosis has been amply demonstrated by the patholo-
gists and clinicians who developed the system. However,
its usefulness has not yet resulted in widespread accept-
ance. For the oral cavity, there is only one study that
reports its use in this anatomic location.[58] In that study
a prognostic significance, similar to the larynx was noted.
However, data on reproducibility are also lacking for this
anatomic area. Further studies should be done to see
whether it has an advantage above the current WHO dys-
plasia system.
Although the histological assessment of the WHO dyspla-
sia system and the Ljubljana system are based on the same
architectural and cytological changes, there is no simple
relationship or overlapping between the classification sys-
tems.[3,11,19,20] Figure 1, figure 2, and figure 3 illustrate
the areas of similarity in the classification systems but also
the problems arising when matching the WHO categories
moderate and severe dysplasia with the Ljubljana category
atypical hyperplasia. According to Gale et al., comparing
the three discussed classification systems, it is unlikely
that they will come together in the very near future. On
the other hand, future discoveries mainly in molecular
biology could be the basis for a single, universal classifica-
tion system for intraepithelial lesions of the UADT.[20]
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